Nicolet Bankshares, Inc. (NIC)

Oncternal Therapeutics Revenue

Nicolet Bankshares had revenue of $94.69M in the quarter ending June 30, 2025, with 13.27% growth. This brings the company's revenue in the last twelve months to $364.02M, up 10.19% year-over-year. In the year 2024, Nicolet Bankshares had annual revenue of $346.48M with 27.15% growth.

• Revenue (ttm): $364.02M
• Revenue Growth: +10.19%
• P/S Ratio: 5.27
• Revenue / Employee: $372,212
• Employees: 978
• Market Cap: 1.87B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	346.48M	73.98M	27.15%
Dec 31, 2023	272.50M	-13.88M	-4.85%
Dec 31, 2022	286.38M	75.96M	36.10%
Dec 31, 2021	210.42M	28.76M	15.83%
Dec 31, 2020	181.66M	13.42M	7.98%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.